Search > Mycosis Fungoides/Sezary Syndrome
My employer runs this trial

Topical Duvelisib for Skin Lymphomas

MD
Overseen ByMedical Director
Age: 18+
Sex: Any
Trial Phase: Phase 1
Sponsor: SecuraBio
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will evaluate the safety and preliminary efficacy of duvelisib topical gel in participants with early-stage mycosis fungoides.

Who Is on the Research Team?

RC

Reuven Chantre, MD

Principal Investigator

Secura Bio, Inc.

Are You a Good Fit for This Trial?

This trial is for people with early-stage mycosis fungoides, a type of skin lymphoma. Participants should have this diagnosis confirmed and be in the early stages of the disease.

Inclusion Criteria

My organs are working normally without recent transfusions.
I have early-stage mycosis fungoides without large lymph nodes.
I have 3 to 5 treatable mycosis fungoides lesions not on my face, neck, or sensitive areas.

Exclusion Criteria

I have had electron beam radiation in the last 3 months.
I have used certain treatments for mycosis fungoides in the past 3 weeks.
I have Stage IIB to IVB mycosis fungoides or Sezary syndrome.
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • Duvelisib

Trial Overview

The study is testing a gel containing duvelisib that is applied directly to affected skin areas. The main goals are to see if it works and how safe it is for treating early-stage mycosis fungoides.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: DuvelisibExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

SecuraBio

Lead Sponsor

Trials
29
Recruited
2,400+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.